Related references
Note: Only part of the references are listed.Interleukin-6 and interleukin-11: same same but different
Christoph Garbers et al.
BIOLOGICAL CHEMISTRY (2013)
An Interleukin-6 Receptor-dependent Molecular Switch Mediates Signal Transduction of the IL-27 Cytokine Subunit p28 (IL-30) via a gp130 Protein Receptor Homodimer
Christoph Garbers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Interleukin-27 expression modifies prostate cancer cell crosstalk with bone and immune cells in vitro
Olga Zolochevska et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice
Stefan Thiem et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Discovery of a Novel Orally Active Small-Molecule gp130 Inhibitor for the Treatment of Ovarian Cancer
Shili Xu et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Bone metastasis from breast cancer involves elevated IL-11 expression and the gp130/STAT3 pathway
Li Ren et al.
MEDICAL ONCOLOGY (2013)
Oncostatin M Is a Growth Factor for Ewing Sarcoma
Emmanuelle David et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells
Liang Zhang et al.
BLOOD (2012)
HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice
Jan Suthaus et al.
BLOOD (2012)
Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells
Yue Wang et al.
CYTOKINE (2012)
Hitting a complex target: an update on interleukin-6 trans-signalling
Georg H. Waetzig et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
IL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling
Daniel Traum et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Small Molecule Inhibitors of Signal Transducer and Activator of Transcription 3 (Stat3) Protein
Bikash Debnath et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
CNTF receptor subunit α as a marker for glioma tumor-initiating cells and tumor grade
Jie Lu et al.
JOURNAL OF NEUROSURGERY (2012)
Antitumor Activities of Interleukin-27 on Melanoma
Hiroshi Nagai et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2012)
Suppressors of Cytokine Signaling (SOCS) Proteins and JAK/STAT Pathways Regulation of T-Cell Inflammation by SOCS1 and SOCS3
Taiga Tamiya et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Juergen Scheller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer
Marina Lesina et al.
CANCER CELL (2011)
Genetic Polymorphisms in Inflammation Pathway Genes and Prostate Cancer Risk
Erika M. Kwon et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer
Chi-Wen Lo et al.
CANCER RESEARCH (2011)
Genetic Ablation of PKC Epsilon Inhibits Prostate Cancer Development and Metastasis in Transgenic Mouse Model of Prostate Adenocarcinoma
Bilal Bin Hafeez et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis
Toshihiro Seike et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
Pharmacological management of Kaposi's sarcoma
Cecilia Sgadari et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
The novel histone deacetylase inhibitor, AR-42, inhibits gp130/Stat3 pathway and induces apoptosis and cell cycle arrest in multiple myeloma cells
Shuhong Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Simon A. Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas
Camilla Pilati et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
The Functions of Signal Transducers and Activators of Transcriptions 1 and 3 as Cytokine-Inducible Proteins
HyeonJoo Cheon et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
Soluble gp130 Regulates Prostate Cancer Invasion and Progression in an Interleukin-6 Dependent and Independent Manner
Shahrokh F. Shariat et al.
JOURNAL OF UROLOGY (2011)
Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells
Yue Wang et al.
CANCER LETTERS (2010)
Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer
Tanya B. Dorff et al.
CLINICAL CANCER RESEARCH (2010)
Signaling through interleukin-6 receptor supports blast cell proliferation in acute myeloblastic leukemia
Marjaana Säily et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis
Yi Li et al.
GUT (2010)
N-Linked Glycosylation Is Essential for the Stability but Not the Signaling Function of the Interleukin-6 Signal Transducer Glycoprotein 130
Georg H. Waetzig et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Crystal Structure of the Entire Ectodomain of gp130 INSIGHTS INTO THE MOLECULAR ASSEMBLY OF THE TALL CYTOKINE RECEPTOR COMPLEXES
Yibin Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation
Simone Radtke et al.
JOURNAL OF CELL SCIENCE (2010)
Essential Roles of IL-6 Trans-Signaling in Colonic Epithelial Cells, Induced by the IL-6/Soluble-IL-6 Receptor Derived from Lamina Propria Macrophages, on the Development of Colitis-Associated Premalignant Cancer in a Murine Model
Satoshi Matsumoto et al.
JOURNAL OF IMMUNOLOGY (2010)
gp130 at the nexus of inflammation, autoimmunity, and cancer
J. S. Silver et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer
Tracy Putoczki et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
A role for IL-27p28 as an antagonist of gp130-mediated signaling
Jason S. Stumhofer et al.
NATURE IMMUNOLOGY (2010)
The signal transducer gp130: Solution structure of the carboxy-terminal domain of the cytokine receptor homology region
Thomas Kernebeck et al.
PROTEIN SCIENCE (2010)
Structural Biology of Shared Cytokine Receptors
Xinquan Wang et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Serpin B3/B4, activated by STAT3, promote survival of squamous carcinoma cells
Simi T. Ahmed et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
Julia Bollrath et al.
CANCER CELL (2009)
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
Sergei Grivennikov et al.
CANCER CELL (2009)
Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney
Rameen Beroukhim et al.
CANCER RESEARCH (2009)
β1 Integrin Adhesion Enhances IL-6-Mediated STAT3 Signaling in Myeloma Cells: Implications for Microenvironment Influence on Tumor Survival and Proliferation
Kenneth H. Shain et al.
CANCER RESEARCH (2009)
Interleukin-6 Regulates Androgen Synthesis in Prostate Cancer Cells
Jae Yeon Chun et al.
CLINICAL CANCER RESEARCH (2009)
Cytokine signalling by gp130 regulates gastric mucosal healing after ulceration and, indirectly, antral tumour progression
Louise M. Judd et al.
JOURNAL OF PATHOLOGY (2009)
Interleukin-11 increases invasiveness of JEG-3 choriocarcinoma cells by modulating STAT3 expression
Pankaj Suman et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2009)
gp130 signaling in bone cell biology: Multiple roles revealed by analysis of genetically altered mice
Natalie A. Sims
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
The Fer Tyrosine Kinase Cooperates with Interleukin-6 to Activate Signal Transducer and Activator of Transcription 3 and Promote Human Prostate Cancer Cell Growth
Amina Zoubeidi et al.
MOLECULAR CANCER RESEARCH (2009)
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
Sandra Rebouissou et al.
NATURE (2009)
Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
Mara Compagno et al.
NATURE (2009)
Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor Growth
Hui Wang et al.
STEM CELLS (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Caspase-mediated cleavage of the signal-transducing IL-6 receptor subunit gp130
Dirk Graf et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
OSM, LIF, its receptors, and its relationship with the malignance in human breast carcinoma (in situ and in infiltrative)
Ignacio Garcia-Tunon et al.
CANCER INVESTIGATION (2008)
BART is essential for nuclear retention of STAT3
Ryuta Muromoto et al.
INTERNATIONAL IMMUNOLOGY (2008)
Antiproliferative activity of IL-27 on melanoma
Takayuki Yoshimoto et al.
JOURNAL OF IMMUNOLOGY (2008)
c-Cbl-dependent monoubiquitination and lysosomal degradation of gp130
Yoshinori Tanaka et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Stromal Gene Signatures in Large-B-Cell Lymphomas
G. Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Conditional gp130 deficient mouse mutants
Nicolas Fasnacht et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
Ups and downs: The STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling
Gabriella Regis et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas
Sizhi Paul Gao et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Transformation of hematopoietic cells and activation of JAK2-V617F by IL-27R, a component of a heterodimeric type I cytokine receptor
Anuradha Pradhan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression
C. B. Jackson et al.
JOURNAL OF PATHOLOGY (2007)
Nucleocytoplasmic shuttling of persistently activated STAT3
Andreas Herrmann et al.
JOURNAL OF CELL SCIENCE (2007)
Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases
A. Hausherr et al.
ONCOGENE (2007)
The dynamics of signal triggering in a gp130-receptor complex
Rishi Matadeen et al.
STRUCTURE (2007)
Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T
Xiaodong Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Gp130 receptor ligands as potential therapeutic targets for obesity
Mark A. Febbraio
JOURNAL OF CLINICAL INVESTIGATION (2007)
Molecular and functional characterization of a soluble form of oncostatin M/interleukin-31 shared receptor
Caroline Diveu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Oncostatin M (OSM) cytostasis of breast tumor cells:: Characterization of an OSM receptor β-specific kernel
Nicholas Underhill-Day et al.
CANCER RESEARCH (2006)
Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas
Yasuo Adachi et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression
Hartmut Halfter et al.
CANCER RESEARCH (2006)
Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis
Peter J. Richards et al.
ARTHRITIS AND RHEUMATISM (2006)
Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain
LX Sun et al.
CANCER CELL (2006)
Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors
JE Korkola et al.
CANCER RESEARCH (2006)
Autocrine interleukin-6/interleukin-6 receptor stimulation in non-small-cell lung cancer
Eric B. Haura et al.
CLINICAL LUNG CANCER (2006)
A form of circulating interleukin-6 receptor component soluble gp130 as a potential interleukin-6 inhibitor in inflammatory bowel disease
K Mitsuyama et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Multiple reasons for an inefficient STAT1 response upon IL-6-type cytokine stimulation
S Haan et al.
CELLULAR SIGNALLING (2005)
Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130
M Howlett et al.
GASTROENTEROLOGY (2005)
Gene signatures of progression and metastasis in renal cell cancer
J Jones et al.
CLINICAL CANCER RESEARCH (2005)
Regulation of gene-activation pathways by pias proteins in the immune system
K Shuai et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Calmodulin-dependent protein kinases phosphorylate gp130 at the serine-based dileucine internalization motif
RM Gibson et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2005)
Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase
S Godoy-Tundidor et al.
PROSTATE (2005)
Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor
G Skiniotis et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
Reverse engineering of regulatory networks in human B cells
K Basso et al.
NATURE GENETICS (2005)
Cutting edge:: IL-10-Independent STAT3 activation by toxoplasma gondii mediates suppression of IL-12 and TNF-α in host macrophages
BA Butcher et al.
JOURNAL OF IMMUNOLOGY (2005)
Interleukin-1β can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells
JI Park et al.
CYTOKINE (2005)
Protein phosphatase type 2A, PP2A, is involved in degradation of gp130
S Mitsuhashi et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2005)
Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor
D Derouet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27
S Pflanz et al.
JOURNAL OF IMMUNOLOGY (2004)
Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate
M Royuela et al.
JOURNAL OF PATHOLOGY (2004)
PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells
S Lentzsch et al.
LEUKEMIA (2004)
Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy
KS Selander et al.
CANCER RESEARCH (2004)
TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling
C Becker et al.
IMMUNITY (2004)
Cardiotrophin-1: Expression in experimental myocardial infarction and potential role in post-MI wound healing
DH Freed et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Functional significance of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) for human myeloma cell growth and survival
R Burger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130
MJ Boulanger et al.
MOLECULAR CELL (2003)
Gene expression profiling identifies molecular subtypes of gliomas
R Shai et al.
ONCOGENE (2003)
Hexameric structure and assembly of the interleukin-6/IL-6 α-receptor/gp130 complex
MJ Boulanger et al.
SCIENCE (2003)
How does interleukin-6 affect the membrane expressions of interleukin-6 receptor and gp130 and the proliferation of the human myeloma cell line OPM-2?
E Kovacs
BIOMEDICINE & PHARMACOTHERAPY (2003)
Functional in vitro studies on the role and regulation of interleukin-6 in human somatotroph pituitary adenomas
JO Thiele et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003)
Viral IL-6-induced cell proliferation and immune evasion of interferon activity
M Chatterjee et al.
SCIENCE (2002)
The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation
T Yamamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice
NC Tebbutt et al.
NATURE MEDICINE (2002)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cells
WC Cheung et al.
LEUKEMIA (2002)
Human herpesvirus 8-derived viral IL-6 induces PTX3 expression in Kaposi's sarcoma cells
M Klouche et al.
AIDS (2002)
Interleukin-6, tumour necrosis factor α and interleukin-1β in patients with renal cell carcinoma
N Yoshida et al.
BRITISH JOURNAL OF CANCER (2002)
Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells
YD Wang et al.
ONCOGENE (2002)
Oncostatin M induces tissue-type plasminogen activator and plasminogen activator inhibitor-1 in Calu-1 lung carcinoma cells
MJ Spence et al.
CYTOKINE (2002)
Prostaglandin E2 stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway
XH Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells
FH Zhan et al.
BLOOD (2002)
Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis
SF Shariat et al.
UROLOGY (2001)
In vitro reconstitution of recognition and activation complexes between interleukin-6 and gp130
DC Chow et al.
BIOCHEMISTRY (2001)
Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure
HG Eiken et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2001)
Structure of an extracellular gp130 cytokine receptor signaling complex
DC Chow et al.
SCIENCE (2001)
Acute activation of gp130 gene expression in bone marrow stromal cells by contact with myeloma-derived lymphoblastic cell line ARH77 cell membranes
HS Juneja et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2001)
Interleukin-11 receptor expression in primary ovarian carcinomas
CL Campbell et al.
GYNECOLOGIC ONCOLOGY (2001)
Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma
CL Campbell et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells
H Halfter et al.
MOLECULAR BRAIN RESEARCH (2000)
CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex
GCA Elson et al.
NATURE NEUROSCIENCE (2000)
Phosphorylation of human gp130 at Ser-782 adjacent to the di-leucine internalization motif - Effects on expression and signaling
RM Gibson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Cloning of novel soluble gp130 and detection of its neutralizing autoantibodies in rheumatoid arthritis
M Tanaka et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells
J De Vos et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells
MR Schneider et al.
CANCER LETTERS (2000)
Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors
ZJ Gu et al.
LEUKEMIA (2000)
Cytokines IL-1 beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNF alpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel
RT Penson et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2000)
Activation of Stat3 and Stat1 DNA binding and transcriptional activity in human brain tumour cell lines by gp130 cytokines
LK Schaefer et al.
CELLULAR SIGNALLING (2000)
Share Paper
